Gender-stratified 9-month comparison of paliperidone extended-release tablets and paliperidone palmitate injection in schizophrenia.

Front Psychiatry · 2025 · PMC12163612 · PMID 40521592

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This advantage was observed as early as 3 months (95% CI: -10.76 to 1.89), though the difference did not reach statistical significance until 9 months.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.